Jeff Yass’s ProShares Ultra CRCL CRCA Stock Holding History

Jeff Yass’s Portfolio CRCA Stock Details CRCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$568K	Buy	44,342 +22,858	+106%	+$881K	﹤0.01%	9608
2026 Q1	$887K	Buy	21,484 +7,384	+52%	+$307K	﹤0.01%	8204
2025 Q4	$570K	Buy	+14,100	New	+$1.21M	﹤0.01%	8473

Other funds holding CRCA

Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

HCM

Hollencrest Capital Management Newport Beach, California $1.54B AUM 30.1% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Jeff Yass's CRCA Position: Q2 2026 in Review

Jeff Yass increased its ProShares Ultra CRCL (CRCA) stake by 106% in Q2 2026, buying an estimated $881K and bringing the position to 44,342 shares worth $568K. The position accounts for ﹤0.01% of the portfolio, ranked #9608.

Jeff Yass first reported a position in CRCA in Q4 2025 and has held it in 3 quarters since. The position peaked at $887K in Q1 2026. 7 funds tracked by Wall St. Rank hold CRCA as of Q2 2026.

Jeff Yass held 44,342 shares of ProShares Ultra CRCL worth $568K as of Q2 2026.
Jeff Yass bought 22,858 ProShares Ultra CRCL shares in Q2 2026, an estimated $881K.
ProShares Ultra CRCL made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #9608 holding.
Jeff Yass first reported a position in ProShares Ultra CRCL in Q4 2025 and has held it in 3 quarters since.
Jeff Yass's ProShares Ultra CRCL position peaked at $887K in Q1 2026.
7 funds tracked by Wall St. Rank held ProShares Ultra CRCL as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.